---
title: CordenPharma vs Siegfried Holding
slug_a: cordenpharma
slug_b: siegfried
site: cdmo
review_signal_gate: closed
canonical_path: /compare/cordenpharma/siegfried
---

# CordenPharma vs Siegfried Holding

Side-by-side profile data from each company listing on this directory.

## CordenPharma

- Profile: [/companies/cordenpharma](/companies/cordenpharma)

CordenPharma — Full-service CDMO offering cGMP development and manufacturing of APIs, lipid excipients, drug products, injectables, peptides, LNPs, oligonucleotides, and oral solid dose across 10 facilities in 6 countries with 3000+ employees.

Services: 21. Modalities: 5. Indications: 0. Locations: 1. Certifications: 2. The strongest documented coverage currently appears in services (21).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Flow Chemistry & Continuous Manufacturing
- Solid-State Chemistry & Polymorph Screening
- Lipid Nanoparticle (LNP) Formulation
- Oligonucleotide Manufacturing
- Peptide Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Prefilled Syringe (PFS) Filling
- Lyophilization (Freeze Drying)
- Oral Solid Dosage Manufacturing
- Inhalation & Nasal Dosage Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Secondary Packaging & Labeling
- Serialization & Track-and-Trace
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Biologics (Other)
- Oligonucleotide
- mRNA
- Peptide

### Development capabilities

- Analytical method development
- Formulation development
- Solid-state characterization

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Lyophilized Vials
- Oral Solid Dose (OSD)
- Prefilled Syringes (PFS)
- HPAPI
- Flow Chemistry

## Siegfried Holding

- Profile: [/companies/siegfried](/companies/siegfried)

Siegfried Holding — Global CDMO with 16 production sites across four continents, offering integrated development and manufacturing from early-phase to commercial scale for drug substance and drug product.

Services: 18. Modalities: 2. Indications: 0. Locations: 6. Certifications: 4. The strongest documented coverage currently appears in services (18).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Controlled Substance Manufacturing
- Flow Chemistry & Continuous Manufacturing
- Viral Vector Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Oral Solid Dosage Manufacturing
- Inhalation & Nasal Dosage Manufacturing
- Ophthalmic Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Cold-Chain Storage & Logistics
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Gene Therapy

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Oral Solid Dose (OSD)
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI
- DEA licensed
- Hydrogenation
- Cryogenic (−80 °C)
- Flow Chemistry